These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19268499)

  • 41. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders.
    Gonda X; Telek T; Juhász G; Lazary J; Vargha A; Bagdy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1782-8. PubMed ID: 18721843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
    Freeman EW; Frye CA; Rickels K; Martin PA; Smith SS
    J Clin Psychopharmacol; 2002 Oct; 22(5):516-20. PubMed ID: 12352277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder.
    Bäckström T; Ekberg K; Hirschberg AL; Bixo M; Epperson CN; Briggs P; Panay N; O'Brien S
    Psychoneuroendocrinology; 2021 Nov; 133():105426. PubMed ID: 34597899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prepulse inhibition of acoustic startle in Japanese patients with chronic schizophrenia.
    Kunugi H; Tanaka M; Hori H; Hashimoto R; Saitoh O; Hironaka N
    Neurosci Res; 2007 Sep; 59(1):23-8. PubMed ID: 17692982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipopolysaccharide reduces tactile startle response magnitude but not prepulse inhibition in rats: a dose-response examination.
    Lockey AJ; Kavaliers M; Ossenkopp KP
    Pharmacol Biochem Behav; 2009 Jul; 93(1):47-53. PubMed ID: 19362574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder.
    Batra NA; Seres-Mailo J; Hanstock C; Seres P; Khudabux J; Bellavance F; Baker G; Allen P; Tibbo P; Hui E; Le Melledo JM
    Biol Psychiatry; 2008 Jun; 63(12):1178-84. PubMed ID: 18061146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Premenstrual dysphoric disorder and changes in frontal alpha asymmetry.
    Baehr E; Rosenfeld P; Miller L; Baehr R
    Int J Psychophysiol; 2004 Apr; 52(2):159-67. PubMed ID: 15050374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
    Ahboucha S; Pomier-Layrargues G; Mamer O; Butterworth RF
    Neurochem Int; 2006 Sep; 49(4):372-8. PubMed ID: 16563564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.
    Epperson CN; Pittman B; Czarkowski KA; Stiklus S; Krystal JH; Grillon C
    Neuropsychopharmacology; 2007 Oct; 32(10):2190-8. PubMed ID: 17314917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of lorazepam on fear-potentiated startle responses in man.
    Graham SJ; Scaife JC; Langley RW; Bradshaw CM; Szabadi E; Xi L; Crumley T; Calder N; Gottesdiener K; Wagner JA
    J Psychopharmacol; 2005 May; 19(3):249-58. PubMed ID: 15888510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progesterone selectively increases amygdala reactivity in women.
    van Wingen GA; van Broekhoven F; Verkes RJ; Petersson KM; Bäckström T; Buitelaar JK; Fernández G
    Mol Psychiatry; 2008 Mar; 13(3):325-33. PubMed ID: 17579609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans.
    Bengtsson SK; Nyberg S; Hedström H; Zingmark E; Jonsson B; Bäckström T; Bixo M
    Psychoneuroendocrinology; 2015 Feb; 52():22-31. PubMed ID: 25459890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of transcription factor AP-2 beta genotype in women with premenstrual dysphoric disorder.
    Damberg M; Westberg L; Berggård C; Landen M; Sundblad C; Eriksson O; Naessén T; Ekman A; Eriksson E
    Neurosci Lett; 2005 Mar; 377(1):49-52. PubMed ID: 15722186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal neurosteroid levels are determinant in shaping adult prepulse inhibition response to hippocampal allopregnanolone in rats.
    Darbra S; Modol L; Vallée M; Pallarès M
    Psychoneuroendocrinology; 2013 Aug; 38(8):1397-406. PubMed ID: 23294582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single administration of testosterone reduces fear-potentiated startle in humans.
    Hermans EJ; Putman P; Baas JM; Koppeschaar HP; van Honk J
    Biol Psychiatry; 2006 May; 59(9):872-4. PubMed ID: 16458259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone.
    Andréen L; Spigset O; Andersson A; Nyberg S; Bäckström T
    Maturitas; 2006 Jun; 54(3):238-44. PubMed ID: 16406399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone.
    Hedström H; Bäckström T; Bixo M; Nyberg S; Wang M; Gideonsson I; Turkmen S
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):643-50. PubMed ID: 25929428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allopregnanolone impairs episodic memory in healthy women.
    Kask K; Bäckström T; Nilsson LG; Sundström-Poromaa I
    Psychopharmacology (Berl); 2008 Aug; 199(2):161-8. PubMed ID: 18551282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased neurosteroid sensitivity--an explanation to symptoms associated with chronic work related stress in women?
    Bäckström T; Bixo M; Nyberg S; Savic I
    Psychoneuroendocrinology; 2013 Jul; 38(7):1078-89. PubMed ID: 23177572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.